Oxymorphone ER: Started Phase III

ENDP is enrolling 200 opioid-experienced patients in

Read the full 75 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE